万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603392 万泰生物

已收盘 08-23 15:00:00

{"stockData":{"symbol":"603392","market":"SH","secType":"STK","nameCN":"万泰生物","latestPrice":69.98,"timestamp":1724396400000,"preClose":68.84,"halted":0,"volume":2590483,"delay":0,"floatShares":1268000000,"shares":1268000000,"eps":-0.1532,"marketStatus":"已收盘","marketStatusCode":5,"change":1.14,"latestTime":"08-23 15:00:00","open":68.09,"high":70.5,"low":67.88,"amount":180000000,"amplitude":0.0381,"askPrice":69.99,"askSize":79,"bidPrice":69.98,"bidSize":52,"shortable":0,"etf":0,"ttmEps":-0.1532,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":68.84,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":75.72,"lowLimit":61.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1268206999,"pbRate":7.07,"roa":"--","roe":"2.05%","epsLYR":0.99,"committee":-0.501639,"marketValue":88749000000,"floatMarketCap":88749000000,"peRate":-456.78851,"changeRate":0.0166,"turnoverRate":0.002,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-08-26。"},"requestUrl":"/m/hq/s/603392/tweets","defaultTab":"tweets","newsList":[{"id":"2462648248","title":"万泰跌落凡间，业绩大双降！","url":"https://stock-news.laohu8.com/highlight/detail?id=2462648248","media":"IVD资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462648248?lang=zh_cn&edition=full","pubTime":"2024-08-25 13:09","pubTimestamp":1724562553,"startTime":"0","endTime":"0","summary":"营收与利润显著下滑根据报告，万泰生物2024年上半年度总营收为7.53亿人民币，同比下降了73.93%。目前，万泰生物的九价HPV疫苗已完成III期临床试验揭盲，并获得了主要数据初步分析结果，这些结果符合预期，为公司未来的疫苗业务增长奠定了坚实基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408251310389f51d0ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408251310389f51d0ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2461561294","title":"医健中报扫描｜万泰生物净利润下滑84.7%，出海能否解决“燃眉之急”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2461561294","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461561294?lang=zh_cn&edition=full","pubTime":"2024-08-23 18:55","pubTimestamp":1724410512,"startTime":"0","endTime":"0","summary":"报告显示，上半年公司实现营业收入13.66亿元，同比下降67.19%；归属于上市公司股东的净利润为2.6亿元，同比下降84.7%。早在此前，沃森生物发布的2024年第一季度财报中显示，2024年第一季度归母净利润为1412.75万元，同比下降91.79%。其中，双价HPV疫苗签发33批次，其中万泰生物签发了25批次，同比下降89%；沃森生物签发了6批次，同比下降74%。包括中国在内的194个国家首次共同承诺消除一种癌症。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231856489f4c0c0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231856489f4c0c0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392"],"gpt_icon":0},{"id":"2461830565","title":"财报透视｜业绩再下滑！万泰生物上半年净利降逾八成 二价HPV疫苗销售不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2461830565","media":"读创客户端","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461830565?lang=zh_cn&edition=full","pubTime":"2024-08-23 10:13","pubTimestamp":1724379206,"startTime":"0","endTime":"0","summary":"万泰生物表示，营收变动的主要原因是公司二价宫颈癌疫苗受九价宫颈癌疫苗扩龄影响以及市场竞争等因素影响，销售不及预期所致。归属于上市公司股东的净利润下降，主要为上述营业收入影响因素。据悉，万泰生物主要从事体外诊断试剂、仪器与疫苗的研发、生产及销售，主要业务分为体外诊断及疫苗两大类领域。截至报告期末，二价HPV疫苗已在各省、自治区、直辖市获得招、补标准入，有效覆盖全国31个省份，约2,839家疾控中心和30,597家接种单位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231028459f4a30df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231028459f4a30df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","159646"],"gpt_icon":0},{"id":"2461734519","title":"万泰生物上半年净利降逾八成，二价宫颈癌疫苗销售收入回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2461734519","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461734519?lang=zh_cn&edition=full","pubTime":"2024-08-22 22:24","pubTimestamp":1724336640,"startTime":"0","endTime":"0","summary":"万泰生物上半年财务数据对于业绩的大幅下降，万泰生物称，主要由于公司二价宫颈癌疫苗持续受九价宫颈癌疫苗扩龄影响以及市场竞争、降库存等因素影响，销售收入较去年同期回落。归母净利润下降主要为上述营业收入影响因素。万泰生物的二价宫颈癌疫苗于2019年底获批上市，是首个国产宫颈癌疫苗。尽管二价疫苗太卷，但万泰生物并未放弃HPV疫苗赛道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082222244395b476df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082222244395b476df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159646","BK0239","603392"],"gpt_icon":0},{"id":"2461031405","title":"万泰生物：2024年半年度营收大幅下滑，净利润同比骤降","url":"https://stock-news.laohu8.com/highlight/detail?id=2461031405","media":"华尔街见闻","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461031405?lang=zh_cn&edition=full","pubTime":"2024-08-22 20:52","pubTimestamp":1724331143,"startTime":"0","endTime":"0","summary":"北京 万泰生物 药业股份有限公司今日发布了2024年半年度财报，显示公司在报告期内的营业收入和净利润均出现大幅下滑。2024年上半年，万泰生物实现营业收入13.66亿元，同比下降67.19%；归属于上市公司股东的净利润为2.60亿元，同比下降84.70%。万泰生物2024年上半年的营业收入为13.66亿元，较上年同期的41.64亿元大幅下降67.19%。截至2024年6月30日，万泰生物的总资产为149.62亿元，较上年度末的157.15亿元下降4.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408222101029f481d18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408222101029f481d18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392"],"gpt_icon":0},{"id":"2461399266","title":"万泰生物：上半年实现归母净利润2.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461399266","media":"新京报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461399266?lang=zh_cn&edition=full","pubTime":"2024-08-22 17:41","pubTimestamp":1724319660,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯 8月22日，万泰生物发布2024年半年度报告。报告期内，公司实现营业收入13.66亿元，同比减少67.19%；实现归属于上市公司股东的净利润2.6亿元，同比减少84.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822174556ab5f1196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822174556ab5f1196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392"],"gpt_icon":0},{"id":"2461396707","title":"V观财报｜万泰生物上半年净利降逾八成 二价HPV疫苗销售不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2461396707","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461396707?lang=zh_cn&edition=full","pubTime":"2024-08-22 17:22","pubTimestamp":1724318543,"startTime":"0","endTime":"0","summary":"对于营收变动，万泰生物表示，主要是公司二价宫颈癌疫苗受九价宫颈癌疫苗扩龄影响...","market":"hk","thumbnail":"http://www.jwview.com/jingwei/08-22/U1049P902T1D604720F10DT20240822172223.jpg","type":0,"news_type":0,"thumbnails":["http://www.jwview.com/jingwei/08-22/U1049P902T1D604720F10DT20240822172223.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.jwview.com/jingwei/html/08-22/604720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zxjw_stock","symbols":["603392","159646","09633"],"gpt_icon":0},{"id":"2461544398","title":"图解万泰生物中报：第二季度单季净利润同比减70.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461544398","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461544398?lang=zh_cn&edition=full","pubTime":"2024-08-22 17:13","pubTimestamp":1724318019,"startTime":"0","endTime":"0","summary":"证券之星消息，万泰生物2024年中报显示，公司主营收入13.66亿元，同比下降67.19%；归母净利润2.6亿元，同比下降84.7%；扣非净利润6352.06万元，同比下降96.09%；其中2024年第二季度，公司单季度主营收入6.14亿元，同比下降51.96%；单季度归母净利润1.35亿元，同比下降70.54%；单季度扣非净利润1425.02万元，同比下降96.62%；负债率14.88%，投资收益6596.56万元，财务费用-3740.73万元，毛利率73.17%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200030787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603392","09633"],"gpt_icon":0},{"id":"2461360163","title":"万泰生物(603392)6月30日股东户数3.77万户，较上期减少8.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461360163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461360163?lang=zh_cn&edition=full","pubTime":"2024-08-22 17:01","pubTimestamp":1724317274,"startTime":"0","endTime":"0","summary":"证券之星消息，近日万泰生物披露，截至2024年6月30日公司股东户数为3.77万户，较3月31日减少3613.0户，减幅为8.74%。在生物制品行业个股中，万泰生物股东户数高于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.38万户。从股价来看，2024年3月31日至2024年6月30日，万泰生物区间跌幅为2.14%，在此期间股东户数减少3613.0户，减幅为8.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200029970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1981816686.USD","BK1200","09633","BK1589","BK0239","603392"],"gpt_icon":0},{"id":"2461360829","title":"万泰生物：8月22日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2461360829","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461360829?lang=zh_cn&edition=full","pubTime":"2024-08-22 16:55","pubTimestamp":1724316944,"startTime":"0","endTime":"0","summary":"每经AI快讯，万泰生物 8月22日晚间发布公告称，公司第六届第三次董事会会议于2024年8月22日以通讯方式召开。审议了《关于公司2024年半年度募集资金存放与实际使用情况的专项报告的议案》等。2023年1至12月份，万泰生物的营业收入构成为：疫苗占比71.86%，体外诊断占比27.82%。截至发稿，万泰生物市值为873亿元。道达号“个股趋势”提醒：1. 万泰生物近30日内北向资金持股量增加61.04万股，占流通股比例增加0.05%；2. 近30日内无机构对万泰生物进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082216560795b3719b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082216560795b3719b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2461821360","title":"万泰生物：业绩说明会定于9月3日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2461821360","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461821360?lang=zh_cn&edition=full","pubTime":"2024-08-22 16:51","pubTimestamp":1724316664,"startTime":"0","endTime":"0","summary":"每经AI快讯，万泰生物 8月22日晚间发布公告称，公司2024年半年度业绩说明会定于2024年9月3日上午11:00-12:00，以上证路演中心网络互动的形式进行。2023年1至12月份，万泰生物的营业收入构成为：疫苗占比71.86%，体外诊断占比27.82%。截至发稿，万泰生物市值为873亿元。道达号“个股趋势”提醒：1. 万泰生物近30日内北向资金持股量增加61.04万股，占流通股比例增加0.05%；2. 近30日内无机构对万泰生物进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408221651349f4740d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408221651349f4740d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2461361570","title":"万泰生物(603392.SH)：上半年净利润2.6亿元 同比下降84.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461361570","media":"格隆汇","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461361570?lang=zh_cn&edition=full","pubTime":"2024-08-22 16:01","pubTimestamp":1724313695,"startTime":"0","endTime":"0","summary":"格隆汇8月22日丨万泰生物(603392.SH)公布半年度报告，2024年上半年，公司实现收入13.66亿元，比上年同期下降67.19%；归属于母公司的净利润为2.6亿元，比上年同期下降84.70%。归属于母公司股东的扣除非经营性损益后的净利润为6,352.06万元，比上年同期下降96.09%，基本每股收益0.21元，比上年同期1.34元下降84.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822160135ab5f0603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822160135ab5f0603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392"],"gpt_icon":0},{"id":"2461667583","title":"万泰生物(603392.SH)上半年净利大跌84.70%至2.60亿元 二价及九价宫颈癌疫苗收入回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2461667583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461667583?lang=zh_cn&edition=full","pubTime":"2024-08-22 15:51","pubTimestamp":1724313070,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万泰生物 发布2024年半年度报告，报告期内公司实现营业收入13.66亿元，同比减少67.19%;归属于上市公司股东的净利润2.60亿元，同比减少84.70%;归属于上市公司股东扣除非经常性损益净利润6352.06万元，同比减少96.09%;基本每股收益0.21元/股。营业收入下降，主要由于公司二价宫颈癌疫苗持续受九价宫颈癌疫苗扩龄影响以及市场竞争、降库存等因素影响，销售收入较去年同期回落。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1168337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603392","BK0239","BK1200","159646","LU1981816686.USD","09633","BK1589"],"gpt_icon":0},{"id":"2461361505","title":"万泰生物：二价宫颈癌疫苗收入回落，上半年归母净利润同比下降84.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461361505","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461361505?lang=zh_cn&edition=full","pubTime":"2024-08-22 15:47","pubTimestamp":1724312838,"startTime":"0","endTime":"0","summary":"万泰生物8月22日公告，2024年上半年公司营业收入13.66亿元，同比下降67.19%；归母净利润为2.6亿元，同比下降84.7%；基本每股收益0.21元。营业收入下降，主要由于公司二价宫颈癌疫苗持续受九价宫颈癌疫苗扩龄影响以及市场竞争、降库存等因素影响，销售收入较去年同期回落。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822154718ab5f04c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822154718ab5f04c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159646","603392"],"gpt_icon":0},{"id":"2461361577","title":"万泰生物：上半年净利2.6亿元，同比下降84.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461361577","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461361577?lang=zh_cn&edition=full","pubTime":"2024-08-22 15:46","pubTimestamp":1724312776,"startTime":"0","endTime":"0","summary":"格隆汇8月22日｜万泰生物发布2024年半年度报告，报告期内，公司实现营业收入1,366,045,101.74元，同比下降67.19%；归属于上市公司股东的净利润为260,480,462.16元，同比下降84.70%。公司总资产为14,962,382,311.14元，较上年度末减少4.79%；归属于上市公司股东的净资产为12,550,736,925.95元，较上年度末减少1.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408221546449f46f895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408221546449f46f895&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2461361509","title":"万泰生物：2024年上半年净利润同比下降84.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461361509","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461361509?lang=zh_cn&edition=full","pubTime":"2024-08-22 15:45","pubTimestamp":1724312700,"startTime":"0","endTime":"0","summary":"万泰生物公告，2024年上半年公司实现营业收入13.66亿元，同比下降67.19%；归属于上市公司股东的净利润为2.6亿元，同比下降84.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082215461995b32749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082215461995b32749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392"],"gpt_icon":0},{"id":"2461332046","title":"【最新转融券余额不足50亿元 降幅达95.54%】金十数据8月22日讯，Wind数据显示，截至8月21日，A股市场转融券余额为49.","url":"https://stock-news.laohu8.com/highlight/detail?id=2461332046","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461332046?lang=zh_cn&edition=full","pubTime":"2024-08-22 11:57","pubTimestamp":1724299033,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SG9999001226.SGD","399300","SG9999001051.SGD","159982","BK1589","BK0187","SGXZ81163826.USD","SGXZ90724238.SGD","SG9999002950.SGD","601009","BK0239","603392","BK1200","SGXZ49509284.SGD","09633","BK0012","BK0183","BK0278","BK0028","BK0188","LU1981816686.USD"],"gpt_icon":0},{"id":"2460025365","title":"万泰生物08月20日主力资金流出571万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2460025365","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460025365?lang=zh_cn&edition=full","pubTime":"2024-08-20 15:19","pubTimestamp":1724138379,"startTime":"0","endTime":"0","summary":"08月20日, 万泰生物股价跌0.01%，报收69.19元，成交金额1.33亿元，换手率0.15%，振幅2.28%，量比0.41。万泰生物今日主力资金净流出571万元，连续3日净流出，上一交易日主力净流出2237万元，今日环比减少74.47%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为70.00%，平均跌幅为2.22%。该股近5个交易日上涨1.47%，主力资金累计净流出5497万元；近20日主力资金累计净流出1.90亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201544049f3ce826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201544049f3ce826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2460012183","title":"幽门螺杆菌概念盘中跳水，万泰生物跌0.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460012183","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460012183?lang=zh_cn&edition=full","pubTime":"2024-08-20 11:27","pubTimestamp":1724124426,"startTime":"0","endTime":"0","summary":"08月20日，幽门螺杆菌概念盘中跳水，截至11点27分，幽门螺杆菌概念整体指数下跌2.02%，报789.860点。从个股上来看，该概念的成分股中，万泰生物跌0.85%，奥赛康、科拓生物、之江生物跌幅居前。从资金上来看，截止发稿，幽门螺杆菌概念概念主力净流入为-1.15亿，其中达安基因受到资金热捧，主力净流入8026.68万；拉长时间线来看，该板块近20日主力资金净流入-17.18亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820112706af97800f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820112706af97800f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2460101663","title":"病毒检测概念盘中跳水，万泰生物跌0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460101663","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460101663?lang=zh_cn&edition=full","pubTime":"2024-08-20 10:15","pubTimestamp":1724120149,"startTime":"0","endTime":"0","summary":"08月20日，病毒检测概念盘中跳水，截至10点15分，病毒检测概念整体指数下跌1.06%，报769.800点。从个股上来看，该概念的成分股中，万泰生物跌0.39%，华大基因、之江生物跌幅居前。从资金上来看，截止发稿，病毒检测概念主力净流入为5357.94万，其中达安基因受到资金热捧，主力净流入6066.08万；拉长时间线来看，该板块近20日主力资金净流入-11.89亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201015499420104a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201015499420104a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-04-29","address":"北京市昌平区科学园路31号","stockEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":0.0206},{"period":"3month","weight":0.1017},{"period":"6month","weight":0.0018},{"period":"1year","weight":0.2609},{"period":"ytd","weight":-0.0642}],"companyName":"北京万泰生物药业股份有限公司","boardCode":"AI0027","perCapita":"33629股","boardName":"医药制造业","registeredCapital":"126820万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":"　　北京万泰生物药业股份有限公司是从事体外诊断试剂、自动化检测设备、疫苗研发生产及销售的高新技术企业,其主要产品有疫苗、免疫诊断试剂、生化试剂、质控品、活性原料。公司获得国家企业技术中心、国家技术创新示范企业、国家地方联合工程实验室、国家知识产权优势企业、博士后科研工作站等95项省级及国家级荣誉称号；公司研发产品获得国家科学技术进步奖二等奖、国家技术发明奖二等奖、北京市科学技术一等奖、亚洲生物技术最佳创新奖及中国专利金奖等30项奖励。","serverTime":1724566033911,"listedPrice":8.75,"stockholders":"37711人(较上一季度减少8.74%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万泰生物,603392,万泰生物股票,万泰生物股票老虎,万泰生物股票老虎国际,万泰生物行情,万泰生物股票行情,万泰生物股价,万泰生物股市,万泰生物股票价格,万泰生物股票交易,万泰生物股票购买,万泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}